Intellia Therapeutics On March 19, Notified Regeneron Pharmaceuticals That Co Is Opting Out Of Its Factor IX Co-Development And Co-Funding Agreement
Intellia Therapeutics於3月19日通知Regeneron Pharmicals,該公司選擇退出其Factor IX共同開發和聯合資助協議
Intellia Therapeutics On March 19, Notified Regeneron Pharmaceuticals That Co Is Opting Out Of Its Factor IX Co-Development And Co-Funding Agreement
Intellia Therapeutics於3月19日通知Regeneron Pharmicals,該公司選擇退出其Factor IX共同開發和聯合資助協議
使用瀏覽器的分享功能,分享給你的好友吧